Dr Thomas Yau, MD | |
8630 Fenton St, Suite 514, Silver Spring, MD 20910-3806 | |
(301) 587-1220 | |
(301) 587-1269 |
Full Name | Dr Thomas Yau |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 31 Years |
Location | 8630 Fenton St, Silver Spring, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275626749 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | D52642 (Maryland) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Retina Group Of Washington, Pllc | 5294702692 | 67 |
News Archive
The Republican Presidential campaign is off to a slow start, but judging by the last week not slow enough. First Mitt Romney defends his ObamaCare prototype in Massachusetts, and now Newt Gingrich has decided to run against House Republicans on Medicare. They must be loving this at the White House.
In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision. The team developed nanoparticles to deliver therapeutic genes to the retina and found that treated mice temporarily retained more eyesight than controls.
Depomed, Inc. today announced that it has received final meeting minutes from the FDA for a pre-NDA meeting related to DM-1796 for postherpetic neuralgia (PHN) held in December 2009. Depomed also commented on recent public disclosures related to the Complete Response letter from the U.S. Food and Drug Administration regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets.
An innovative new medical program in Queensland will use the latest technology to help treat children living in remote Indigenous communities.
IRIN examines "whether a new generation of social protection schemes, aimed at reducing poverty and often using cash transfers to the poorest, can be harnessed to bring down the rate of tuberculosis (TB) in developing countries."
› Verified 4 days ago
Entity Name | Silver Spring Eye Llc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881778587 PECOS PAC ID: 6507751112 Enrollment ID: O20040220000732 |
News Archive
The Republican Presidential campaign is off to a slow start, but judging by the last week not slow enough. First Mitt Romney defends his ObamaCare prototype in Massachusetts, and now Newt Gingrich has decided to run against House Republicans on Medicare. They must be loving this at the White House.
In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision. The team developed nanoparticles to deliver therapeutic genes to the retina and found that treated mice temporarily retained more eyesight than controls.
Depomed, Inc. today announced that it has received final meeting minutes from the FDA for a pre-NDA meeting related to DM-1796 for postherpetic neuralgia (PHN) held in December 2009. Depomed also commented on recent public disclosures related to the Complete Response letter from the U.S. Food and Drug Administration regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets.
An innovative new medical program in Queensland will use the latest technology to help treat children living in remote Indigenous communities.
IRIN examines "whether a new generation of social protection schemes, aimed at reducing poverty and often using cash transfers to the poorest, can be harnessed to bring down the rate of tuberculosis (TB) in developing countries."
› Verified 4 days ago
Entity Name | The Retina Group Of Washington, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225001654 PECOS PAC ID: 5294702692 Enrollment ID: O20040915000226 |
News Archive
The Republican Presidential campaign is off to a slow start, but judging by the last week not slow enough. First Mitt Romney defends his ObamaCare prototype in Massachusetts, and now Newt Gingrich has decided to run against House Republicans on Medicare. They must be loving this at the White House.
In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision. The team developed nanoparticles to deliver therapeutic genes to the retina and found that treated mice temporarily retained more eyesight than controls.
Depomed, Inc. today announced that it has received final meeting minutes from the FDA for a pre-NDA meeting related to DM-1796 for postherpetic neuralgia (PHN) held in December 2009. Depomed also commented on recent public disclosures related to the Complete Response letter from the U.S. Food and Drug Administration regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets.
An innovative new medical program in Queensland will use the latest technology to help treat children living in remote Indigenous communities.
IRIN examines "whether a new generation of social protection schemes, aimed at reducing poverty and often using cash transfers to the poorest, can be harnessed to bring down the rate of tuberculosis (TB) in developing countries."
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Thomas Yau, MD 8630 Fenton St, Suite 514, Silver Spring, MD 20910-3806 Ph: (301) 587-1220 | Dr Thomas Yau, MD 8630 Fenton St, Suite 514, Silver Spring, MD 20910-3806 Ph: (301) 587-1220 |
News Archive
The Republican Presidential campaign is off to a slow start, but judging by the last week not slow enough. First Mitt Romney defends his ObamaCare prototype in Massachusetts, and now Newt Gingrich has decided to run against House Republicans on Medicare. They must be loving this at the White House.
In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision. The team developed nanoparticles to deliver therapeutic genes to the retina and found that treated mice temporarily retained more eyesight than controls.
Depomed, Inc. today announced that it has received final meeting minutes from the FDA for a pre-NDA meeting related to DM-1796 for postherpetic neuralgia (PHN) held in December 2009. Depomed also commented on recent public disclosures related to the Complete Response letter from the U.S. Food and Drug Administration regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets.
An innovative new medical program in Queensland will use the latest technology to help treat children living in remote Indigenous communities.
IRIN examines "whether a new generation of social protection schemes, aimed at reducing poverty and often using cash transfers to the poorest, can be harnessed to bring down the rate of tuberculosis (TB) in developing countries."
› Verified 4 days ago
Arusha Gupta, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8630 Fenton St, Suite 514, Silver Spring, MD 20910 Phone: 301-587-1220 | |
Aziz Alexander Khanifar, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8630 Fenton St Ste 1104, Retina Group Of Washington, Silver Spring, MD 20910 Phone: 301-495-2357 Fax: 301-495-2359 | |
Dr. Beth Alexandra Schwartz, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10101 Colesville Rd, Silver Spring, MD 20901 Phone: 301-754-0101 Fax: 301-754-0103 | |
Dr. William D O'donnell, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2101 Medical Park Dr, Silver Spring, MD 20902 Phone: 301-681-6600 Fax: 301-681-3799 | |
Dr. Aisha Macedo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2101 Medical Park Dr Ste 101, Silver Spring, MD 20902 Phone: 301-681-6600 | |
Julie G Gutmark, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8630 Fenton St, Suite 130, Silver Spring, MD 20910 Phone: 301-588-1177 Fax: 301-589-5245 |